The researchers matched adults starting treatment with GLP-1 receptor agonists 1:1 with those initiating DPP-4 inhibitors based on age, sex, race, hemoglobin A1c levels, BMI, underlying comorbidities, commonly used medications, and diabetes therapy
contraindicated in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 Risk of diabetic retinopathy complications in patients with pre-existing retinopathy Potential for acute kidney injury, particularly related to dehydration Caution or avoidance in severe gastroparesis or severe gastrointestinal disease Suicidality warning for weight-management indications (Wegovy, Saxenda) Potential for altered absorption of oral medications due to delayed gastric emptying In older adults with cognitive impairment, medication adherence may be challenging, and gastrointestinal side effects could lead to dehydration or nutritional deficiencies
adults and 1 billion people worldwide
Both Epithalon and Thymalin are peptide bioregulators developed from the same Russian longevity research tradition (Khavinson peptides)
Since people choosing to de-escalate their GLP-1 therapy might also be more motivated to adopt behavioral strategies for improving their health, there might be underlying selection bias in the study population
But what exactly are copper peptides, and how can they be effectively incorporated into your skincare routine